LLY vs MRK — stock comparison
Eli Lilly and Company (LLY) vs Merck & Co., Inc. (MRK): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, LLY grades higher (A 84 vs C 48). Not investment advice.
1-year price performance — higher line = stronger return
■ LLY +37.7%■ MRK +63.3%Past year, both rebased to 100
| LLY | MRK | |
|---|---|---|
| Traddx grade | A (84) | C (48) |
| Price | $1,157.14 | $140.88 |
| Today | 1.23% | 0.96% |
| P/E | 40.30 | 77.40 |
| Net margin | 33.90% | 7.00% |
| Revenue (TTM) | $75,931.80M | $65,975.00M |
| Debt / equity | — | — |
| 52-week high | $1,292.65 | $156.92 |
| 52-week low | $783.85 | $82.01 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open LLY live → Open MRK live →